ACE inhibitors and calcium channel antagonists the safest bets for paediatric hypertension

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.21, Iss.11, 2005-11, pp. : 14-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitors: survival benefit over calcium channel antagonists

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Calcium Channel Antagonists in the Treatment of Hypertension

By Weber M.A.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 6, 2002-01 ,pp. : 415-431

Adis International

Access to resources Recommend Favorite

Comparison of Losartan with ACE Inhibitors and Dihydropyridine Calcium Channel Antagonists: A Pilot Study of Prescription-Event Monitoring in Japan

By Samizo K.

Drug Safety, Vol. 25, Iss. 11, 2002-01 ,pp. : 811-821

Adis International

Access to resources Recommend Favorite

Use of Calcium Channel Antagonists for the Treatment of Hypertension in the Elderly

By Hans-Michael Steffen

Drugs & Aging, Vol. 21, Iss. 9, 2004-01 ,pp. : 565-581

Adis International

Access to resources Recommend Favorite

Dihydropyridine Calcium Channel Antagonists in the Management of Hypertension

By Epstein Benjamin J.

Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. : 1309-1327

Adis International

Access to resources Recommend Favorite